Robotic Radiotherapy Market Forecasts to 2032 – Global Analysis By Product (Radiotherapy Systems, Software, 3D Cameras (Surface Guided Radiation Therapy - SGRT) and Other Products), Technology (Linear Accelerators (LINACs), Stereotactic Radiation Therapy

According to Stratistics MRC, the Global Transfer Membrane Market is accounted for $461.2 million in 2025 and is expected to reach $702.7 million by 2032 growing at a CAGR of 6.2% during the forecast period. Transfer membrane is a specialized porous material used in molecular biology and biochemistry to facilitate the transfer of biomolecules, such as proteins or nucleic acids, from a gel onto a solid support for analysis. Typically composed of nitrocellulose or polyvinylidene fluoride (PVDF), it ensures efficient binding and retention of target molecules during techniques like Western blotting or Southern blotting. Its high affinity for biomolecules enables precise detection, quantification, and characterization in research and diagnostic applications

According to the European Commission Industrial R&D Investment prediction, data updated in December 2022, the United States planned to spend more than USD 679 billion on research and development in 2022. It was anticipated that China would spend roughly USD 551.1 billion on R&D in 2022.

Market Dynamics:

Driver:

Increasing funding for life sciences research

Governments and private institutions are investing heavily in biotechnology and molecular diagnostics, leading to advancements in membrane technologies. This surge in funding supports the development of innovative applications such as Western blotting and nucleic acid analysis, enhancing research efficiency. Additionally, pharmaceutical and biopharmaceutical companies are expanding their R&D efforts, further boosting demand for high-performance transfer membranes. As a result, the market is witnessing steady growth, fueled by continuous scientific exploration and technological improvements.

Restraint:

Complexity of membrane selection and customization

Researchers must carefully evaluate membrane properties, including pore size, binding affinity, and compatibility with detection methods, to ensure optimal performance. The availability of multiple membrane types, such as nitrocellulose, PVDF, and nylon, adds to the complexity, requiring specialized knowledge for selection. Additionally, customization demands precise manufacturing processes, increasing production costs and time. These factors create barriers for new entrants and slow down procurement decisions, impacting market expansion.

Opportunity:

Development of novel membrane materials

Advances in polymer science and nanotechnology are enabling the creation of membranes with enhanced sensitivity, durability, and specificity. Researchers are exploring bioengineered membranes that improve protein and nucleic acid transfer efficiency, catering to evolving laboratory needs. Additionally, sustainability concerns are driving the demand for eco-friendly membrane alternatives, encouraging manufacturers to innovate expected to reshape the industry landscape.

Threat:

Rapid advancements in alternative analytical techniques

Emerging technologies such as microfluidics, digital PCR, and automated imaging systems are reducing reliance on traditional membrane-based assays. These alternatives offer higher precision, faster processing times, and reduced sample consumption, making them attractive to researchers. As laboratories transition to more automated and integrated workflows, the demand for conventional transfer membranes may decline.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the transfer membrane market, influencing both supply chains and research priorities. While disruptions in manufacturing and logistics led to temporary shortages, the heightened focus on molecular diagnostics and infectious disease research increased demand for membranes. Additionally, the pandemic underscored the importance of efficient biomolecule transfer, prompting investments in high-quality membranes.

The nylon transfer membranes segment is expected to be the largest during the forecast period

The nylon transfer membranes segment is expected to account for the largest market share during the forecast period due to its exceptional durability and strong binding capacity. Nylon membranes effectively retain proteins, making them highly suitable for applications such as Western blotting. Their adaptability across multiple detection techniques enhances their utility in research settings. Additionally, their efficiency in biomolecule transfer and compatibility with advanced staining methods contribute to their growing preference.

The semi-dry electrotransfer segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the semi-dry electrotransfer segment is predicted to witness the highest growth rate driven by its rapid processing capabilities and minimal buffer consumption. This technique is favored for its ability to accelerate transfer time while ensuring consistent molecular retention. With increasing demand for cost-effective and high-speed blotting solutions, laboratories are shifting toward semi-dry methods to streamline workflows.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its well-established biotechnology infrastructure and robust investments in life sciences research. The presence of leading pharmaceutical companies and advanced research institutions fosters continual innovation in transfer membrane applications. Additionally, strong government funding for molecular diagnostics and proteomics research reinforces the region’s market leadership, driving sustained demand for high-quality membranes.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR supported by rising healthcare investments and growing adoption of molecular analysis techniques. Countries like China and India are significantly expanding their research capabilities, fostering greater demand for transfer membranes. Increasing awareness of advanced diagnostic tools and government initiatives aimed at strengthening life sciences infrastructure are contributing to rapid market growth

Key players in the market

Some of the key players in Transfer Membrane Market include Abcam, Advansta, ATTO Corporation, Azure Biosystems, Bio-Rad Laboratories, Carl Roth, Cytiva, GE Healthcare, Merck, Neogen Corporation, Pall Corporation, PerkinElmer, Roche Diagnostics, Santa Cruz Biotechnology Inc., Sartorius AG, Thermo Fisher Scientific and MilliporeSigma.

Key Developments:

In May 2025, Roche Diagnostics announced a strategic collaboration with Broad Clinical Labs to develop applications using Roche's SBX sequencing technology. The partnership aims to accelerate the adoption of cutting-edge sequencing solutions in clinical genomics.

In April 2025, Merck entered into a definitive agreement to acquire SpringWorks Therapeutics, a U.S. biopharmaceutical company. The acquisition aims to accelerate Merck's growth in the healthcare sector.

In March 2025, GE Healthcare announced the U.S. launch of Flyrcado, a unit dose PET myocardial perfusion imaging agent. Flyrcado aims to enhance cardiac imaging by providing improved diagnostic accuracy.

Product Types Covered:
• Nitrocellulose Transfer Membranes
• Polyvinylidene Fluoride (PVDF) Transfer Membranes
• Nylon Transfer Membranes
• Other Product Types

Transfer Methods Covered:
• Wet or Tank Electrotransfer
• Semi-Dry Electrotransfer
• Dry Electrotransfer

Pore Sizes Covered:
• <0.2 µm
• 0.2–0.45 µm
• >0.45 µm

Applications Covered:
• Western Blotting
• Southern Blotting
• Northern Blotting
• Protein Sequencing & Amino Acid Analysis
• Dot/Slot Blotting
• Immunoblotting
• Other Applications

End Users Covered:
• Academic & Research Institutions
• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Contract Development & Manufacturing Organizations (CDMOs)
• Contract Research Organizations (CROs)
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Robotic Radiotherapy Market, By Product
5.1 Introduction
5.2 Radiotherapy Systems
5.2.1 CyberKnife
5.2.2 Gamma Knife
5.2.3 Linear Accelerators (LINACs) with Robotic Patient Positioning
5.3 Software
5.3.1 Treatment Planning Systems (TPS)
5.3.2 Image-Guided Radiation Therapy (IGRT) software
5.3.3 Adaptive Radiotherapy (ART) software
5.4 3D Cameras (Surface Guided Radiation Therapy - SGRT)
5.5 Other Products
6 Global Robotic Radiotherapy Market, By Technology
6.1 Introduction
6.2 Linear Accelerators (LINACs)
6.3 Stereotactic Radiation Therapy (SRT) Systems
6.4 Particle Therapy
6.5 Image-Guided Radiation Therapy (IGRT)
6.6 Intensity-Modulated Radiation Therapy (IMRT)
6.7 Other Technologies
7 Global Robotic Radiotherapy Market, By Application
7.1 Introduction
7.2 Lung Cancer & Prostate Cancer
7.3 Breast Cancer & Colorectal Cancer
7.4 Brain Tumors & Spinal Tumors
7.5 Liver Cancer & Pancreatic Cancer
7.6 Other Applications
8 Global Robotic Radiotherapy Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Cancer Research Institutes
8.4 Ambulatory Surgical Centers
8.5 Specialty Clinics
8.6 Academic & Research Institutions
8.7 Other End Users
9 Global Robotic Radiotherapy Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Accuray Incorporated
11.2 Varian Medical Systems
11.3 Elekta AB
11.4 Mevion Medical Systems
11.5 Hitachi Ltd.
11.6 ViewRay Inc.
11.7 IBA Group
11.8 Reflexion Medical
11.9 Theragenics Corporation
11.10 Medtronic
11.11 CIVCO Radiotherapy
11.12 Bionix Radiation Therapy
11.13 Zap Surgical Systems
11.14 Mitsubishi Electric Corporation
11.15 RaySearch Laboratories
11.16 Sumitomo Heavy Industries
11.17 Nordion Inc.
11.18 P-Cure Ltd.
List of Tables
Table 1 Global Robotic Radiotherapy Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Robotic Radiotherapy Market Outlook, By Product (2024-2032) ($MN)
Table 3 Global Robotic Radiotherapy Market Outlook, By Radiotherapy Systems (2024-2032) ($MN)
Table 4 Global Robotic Radiotherapy Market Outlook, By CyberKnife (2024-2032) ($MN)
Table 5 Global Robotic Radiotherapy Market Outlook, By Gamma Knife (2024-2032) ($MN)
Table 6 Global Robotic Radiotherapy Market Outlook, By Linear Accelerators (LINACs) with Robotic Patient Positioning (2024-2032) ($MN)
Table 7 Global Robotic Radiotherapy Market Outlook, By Software (2024-2032) ($MN)
Table 8 Global Robotic Radiotherapy Market Outlook, By Treatment Planning Systems (TPS) (2024-2032) ($MN)
Table 9 Global Robotic Radiotherapy Market Outlook, By Image-Guided Radiation Therapy (IGRT) software (2024-2032) ($MN)
Table 10 Global Robotic Radiotherapy Market Outlook, By Adaptive Radiotherapy (ART) software (2024-2032) ($MN)
Table 11 Global Robotic Radiotherapy Market Outlook, By 3D Cameras (Surface Guided Radiation Therapy - SGRT) (2024-2032) ($MN)
Table 12 Global Robotic Radiotherapy Market Outlook, By Other Products (2024-2032) ($MN)
Table 13 Global Robotic Radiotherapy Market Outlook, By Technology (2024-2032) ($MN)
Table 14 Global Robotic Radiotherapy Market Outlook, By Linear Accelerators (LINACs) (2024-2032) ($MN)
Table 15 Global Robotic Radiotherapy Market Outlook, By Stereotactic Radiation Therapy (SRT) Systems (2024-2032) ($MN)
Table 16 Global Robotic Radiotherapy Market Outlook, By Particle Therapy (2024-2032) ($MN)
Table 17 Global Robotic Radiotherapy Market Outlook, By Image-Guided Radiation Therapy (IGRT) (2024-2032) ($MN)
Table 18 Global Robotic Radiotherapy Market Outlook, By Intensity-Modulated Radiation Therapy (IMRT) (2024-2032) ($MN)
Table 19 Global Robotic Radiotherapy Market Outlook, By Other Technologies (2024-2032) ($MN)
Table 20 Global Robotic Radiotherapy Market Outlook, By Application (2024-2032) ($MN)
Table 21 Global Robotic Radiotherapy Market Outlook, By Lung Cancer & Prostate Cancer (2024-2032) ($MN)
Table 22 Global Robotic Radiotherapy Market Outlook, By Breast Cancer & Colorectal Cancer (2024-2032) ($MN)
Table 23 Global Robotic Radiotherapy Market Outlook, By Brain Tumors & Spinal Tumors (2024-2032) ($MN)
Table 24 Global Robotic Radiotherapy Market Outlook, By Liver Cancer & Pancreatic Cancer (2024-2032) ($MN)
Table 25 Global Robotic Radiotherapy Market Outlook, By Other Applications (2024-2032) ($MN)
Table 26 Global Robotic Radiotherapy Market Outlook, By End User (2024-2032) ($MN)
Table 27 Global Robotic Radiotherapy Market Outlook, By Hospitals (2024-2032) ($MN)
Table 28 Global Robotic Radiotherapy Market Outlook, By Cancer Research Institutes (2024-2032) ($MN)
Table 29 Global Robotic Radiotherapy Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
Table 30 Global Robotic Radiotherapy Market Outlook, By Specialty Clinics (2024-2032) ($MN)
Table 31 Global Robotic Radiotherapy Market Outlook, By Academic & Research Institutions (2024-2032) ($MN)
Table 32 Global Robotic Radiotherapy Market Outlook, By Other End Users (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings